Meeder Asset Management’s Bio-Rad Laboratories Class A BIO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-189
| Closed | -$65.4K | – | 868 |
|
|
2024
Q1 | $65.4K | Sell |
189
-267
| -59% | -$87.8K | ﹤0.01% | 362 |
|
|
2023
Q4 | $147K | Hold |
456
| – | – | 0.01% | 357 |
|
|
2023
Q3 | $163K | Hold |
456
| – | – | 0.01% | 330 |
|
|
2023
Q2 | $173K | Hold |
456
| – | – | 0.01% | 340 |
|
|
2023
Q1 | $218K | Buy |
+456
| New | +$213K | 0.02% | 295 |
|
|
2022
Q4 | – | Sell |
-73
| Closed | -$30K | – | 924 |
|
|
2022
Q3 | $30K | Sell |
73
-134
| -65% | -$66.8K | ﹤0.01% | 978 |
|
|
2022
Q2 | $102K | Sell |
207
-145
| -41% | -$75.5K | 0.01% | 728 |
|
|
2022
Q1 | $198K | Sell |
352
-624
| -64% | -$376K | 0.01% | 656 |
|
|
2021
Q4 | $738K | Buy |
976
+48
| +5% | +$35.9K | 0.07% | 171 |
|
|
2021
Q3 | $692K | Sell |
928
-21
| -2% | -$15.7K | 0.04% | 336 |
|
|
2021
Q2 | $611K | Sell |
949
-234
| -20% | -$142K | 0.03% | 406 |
|
|
2021
Q1 | $676K | Buy |
1,183
+1,141
| +2,717% | +$676K | 0.03% | 354 |
|
|
2020
Q4 | $24K | Sell |
42
-968
| -96% | -$551K | 0.01% | 751 |
|
|
2020
Q3 | $521K | Buy |
1,010
+39
| +4% | +$19.8K | 0.03% | 348 |
|
|
2020
Q2 | $440K | Buy |
971
+7
| +0.7% | +$3.09K | 0.03% | 403 |
|
|
2020
Q1 | $339K | Buy |
964
+355
| +58% | +$131K | 0.03% | 436 |
|
|
2019
Q4 | $225K | Buy |
609
+19
| +3% | +$6.7K | 0.01% | 567 |
|
|
2019
Q3 | $197K | Buy |
590
+450
| +321% | +$147K | 0.01% | 608 |
|
|
2019
Q2 | $44K | Buy |
140
+3
| +2% | +$898 | ﹤0.01% | 983 |
|
|
2019
Q1 | $42K | Hold |
137
| – | – | ﹤0.01% | 911 |
|
|
2018
Q4 | $32K | Sell |
137
-3,407
| -96% | -$914K | ﹤0.01% | 924 |
|
|
2018
Q3 | $1.11M | Buy |
3,544
+1,647
| +87% | +$511K | 0.08% | 208 |
|
|
2018
Q2 | $547K | Buy |
1,897
+1,842
| +3,349% | +$509K | 0.05% | 351 |
|
|
2018
Q1 | $14K | Sell |
55
-216
| -80% | -$55K | ﹤0.01% | 974 |
|
|
2017
Q4 | $65K | Sell |
271
-347
| -56% | -$84.1K | 0.01% | 635 |
|
|
2017
Q3 | $137K | Buy |
618
+600
| +3,333% | +$135K | 0.01% | 519 |
|
|
2017
Q2 | $4K | Buy |
+18
| New | +$3.92K | ﹤0.01% | 1239 |
|
|
2016
Q4 | – | Sell |
-648
| Closed | -$106K | – | 981 |
|
|
2016
Q3 | $106K | Sell |
648
-1,207
| -65% | -$183K | 0.01% | 595 |
|
|
2016
Q2 | $266K | Buy |
1,855
+716
| +63% | +$102K | 0.02% | 532 |
|
|
2016
Q1 | $156K | Buy |
1,139
+1,128
| +10,255% | +$148K | 0.01% | 623 |
|
|
2015
Q4 | $2K | Buy |
+11
| New | +$1.52K | ﹤0.01% | 794 |
|
|
2014
Q4 | – | Sell |
-4,225
| Closed | -$479K | – | 450 |
|
|
2014
Q3 | $479K | Hold |
4,225
| – | – | 0.07% | 257 |
|
|
2014
Q2 | $506K | Buy |
+4,225
| New | +$516K | 0.08% | 222 |
|
|
2013
Q4 | – | Sell |
-25,760
| Closed | -$3.03M | – | 347 |
|
|
2013
Q3 | $3.03M | Hold |
25,760
| – | – | 0.58% | 49 |
|
|
2013
Q2 | $2.89M | Buy |
+25,760
| New | +$3.02M | 0.57% | 60 |
|
Other funds holding BIO
VAM
